← Eichor
Study identifier: NCT06575218 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effectiveness of Virtual Reality Training Program

Condition: Alzheimer Disease  ·  Sponsor: Yeditepe University

PhaseNA
Planned participants45
Who can joinAll sexes, 55 Years to 90 Years
Healthy volunteersYes

About this study

Alzheimer's disease is the most common type of dementia, accounting for 50% of all cases. Advanced age is a significant risk factor for AD. Virtual Reality (VR) is an interactive video game technology that provides computer-generated environments that include physical activity and provide users with experiences similar to those in the real world. VR technology can be used for rehabilitation purposes in individuals with various orthopedic and neurological disorders due to its ability to enhance motor, cognitive learning and neural plasticity (1,2). The aim of our study was to examine the effect of the Virtual Reality Training Program on cognition in individuals with Alzheimer's disease living in the community.

This description comes directly from the study's public registry record.

Talk to the study team

Ebru Akbuga Koc  ·  216  ·  ebru.akbuga@yeditepe.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Ebru Akbuğa KoçIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06575218